Literature DB >> 29563141

Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.

Judit Balog1, Remko Goossens1, Richard J L F Lemmers1, Kirsten R Straasheijm1, Patrick J van der Vliet1, Anita van den Heuvel1, Chiara Cambieri2, Nicolas Capet3, Léonard Feasson4,5, Veronique Manel6, Julian Contet7, Marjolein Kriek8, Colleen M Donlin-Smith9, Claudia A L Ruivenkamp8, Patricia Heard10, Stephen J Tapscott11, Jannine D Cody10, Rabi Tawil9, Sabrina Sacconi3,7, Silvère M van der Maarel1.   

Abstract

BACKGROUND: 18p deletion syndrome is a rare disorder caused by partial or full monosomy of the short arm of chromosome 18. Clinical symptoms caused by 18p hemizygosity include cognitive impairment, mild facial dysmorphism, strabismus and ptosis. Among other genes, structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) is hemizygous in most patients with 18p deletions. Digenic inheritance of a SMCHD1 mutation and a moderately sized D4Z4 repeat on a facioscapulohumeral muscular dystrophy (FSHD) permissive genetic background of chromosome 4 can cause FSHD type 2 (FSHD2).
OBJECTIVES: Since 12% of Caucasian individuals harbour moderately sized D4Z4 repeats on an FSHD permissive background, we tested if people with 18p deletions are at risk of developing FSHD.
METHODS: To test our hypothesis we studied different cellular systems originating from individuals with 18p deletions not presenting FSHD2 phenotype for transcriptional and epigenetic characteristics of FSHD at D4Z4. Furthermore, individuals with an idiopathic muscle phenotype and an 18p deletion were subjected to neurological examination.
RESULTS: Primary fibroblasts hemizygous for SMCHD1 have a D4Z4 chromatin structure comparable with FSHD2 concomitant with DUX4 expression after transdifferentiation into myocytes. Neurological examination of 18p deletion individuals from two independent families with a moderately sized D4Z4 repeat identified muscle features compatible with FSHD.
CONCLUSIONS: 18p deletions leading to haploinsufficiency of SMCHD1, together with a moderately sized FSHD permissive D4Z4 allele, can associate with symptoms and molecular features of FSHD. We propose that patients with 18p deletion should be characterised for their D4Z4 repeat size and haplotype and monitored for clinical features of FSHD. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  18p deletion; DUX4; FSHD; SMCHD1; muscle misease

Mesh:

Substances:

Year:  2018        PMID: 29563141      PMCID: PMC6019561          DOI: 10.1136/jmedgenet-2017-105153

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy.

Authors:  Petra G M van Overveld; Richard J F L Lemmers; Lodewijk A Sandkuijl; Leo Enthoven; Sara T Winokur; Floor Bakels; George W Padberg; Gert-Jan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  Nat Genet       Date:  2003-11-23       Impact factor: 38.330

2.  High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications.

Authors:  Tamim H Shaikh; Xiaowu Gai; Juan C Perin; Joseph T Glessner; Hongbo Xie; Kevin Murphy; Ryan O'Hara; Tracy Casalunovo; Laura K Conlin; Monica D'Arcy; Edward C Frackelton; Elizabeth A Geiger; Chad Haldeman-Englert; Marcin Imielinski; Cecilia E Kim; Livija Medne; Kiran Annaiah; Jonathan P Bradfield; Elvira Dabaghyan; Andrew Eckert; Chioma C Onyiah; Svetlana Ostapenko; F George Otieno; Erin Santa; Julie L Shaner; Robert Skraban; Ryan M Smith; Josephine Elia; Elizabeth Goldmuntz; Nancy B Spinner; Elaine H Zackai; Rosetta M Chiavacci; Robert Grundmeier; Eric F Rappaport; Struan F A Grant; Peter S White; Hakon Hakonarson
Journal:  Genome Res       Date:  2009-07-10       Impact factor: 9.043

3.  Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.

Authors:  Richard J L F Lemmers; Jelle J Goeman; Patrick J van der Vliet; Merlijn P van Nieuwenhuizen; Judit Balog; Marianne Vos-Versteeg; Pilar Camano; Maria Antonia Ramos Arroyo; Ivonne Jerico; Mark T Rogers; Daniel G Miller; Meena Upadhyaya; Jan J G M Verschuuren; Adolfo Lopez de Munain Arregui; Baziel G M van Engelen; George W Padberg; Sabrina Sacconi; Rabi Tawil; Stephen J Tapscott; Bert Bakker; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2014-09-25       Impact factor: 6.150

4.  Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.

Authors:  Richard J L F Lemmers; Marlinde L van den Boogaard; Patrick J van der Vliet; Colleen M Donlin-Smith; Sharon P Nations; Claudia A L Ruivenkamp; Patricia Heard; Bert Bakker; Stephen Tapscott; Jannine D Cody; Rabi Tawil; Silvère M van der Maarel
Journal:  Hum Mutat       Date:  2015-05-20       Impact factor: 4.878

Review 5.  Facioscapulohumeral Dystrophy.

Authors:  Leo H Wang; Rabi Tawil
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

6.  Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).

Authors:  Weihua Zeng; Jessica C de Greef; Yen-Yun Chen; Richard Chien; Xiangduo Kong; Heather C Gregson; Sara T Winokur; April Pyle; Keith D Robertson; John A Schmiesing; Virginia E Kimonis; Judit Balog; Rune R Frants; Alexander R Ball; Leslie F Lock; Peter J Donovan; Silvère M van der Maarel; Kyoko Yokomori
Journal:  PLoS Genet       Date:  2009-07-10       Impact factor: 5.917

7.  Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.

Authors:  Lauren Snider; Linda N Geng; Richard J L F Lemmers; Michael Kyba; Carol B Ware; Angelique M Nelson; Rabi Tawil; Galina N Filippova; Silvère M van der Maarel; Stephen J Tapscott; Daniel G Miller
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

8.  Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.

Authors:  Takako I Jones; Chi Yan; Peter C Sapp; Diane McKenna-Yasek; Peter B Kang; Colin Quinn; Johnny S Salameh; Oliver D King; Peter L Jones
Journal:  Clin Epigenetics       Date:  2014-10-29       Impact factor: 6.551

9.  Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS.

Authors:  M Mattheisen; J F Samuels; Y Wang; B D Greenberg; A J Fyer; J T McCracken; D A Geller; D L Murphy; J A Knowles; M A Grados; M A Riddle; S A Rasmussen; N C McLaughlin; E L Nurmi; K D Askland; H-D Qin; B A Cullen; J Piacentini; D L Pauls; O J Bienvenu; S E Stewart; K-Y Liang; F S Goes; B Maher; A E Pulver; Y Y Shugart; D Valle; C Lange; G Nestadt
Journal:  Mol Psychiatry       Date:  2014-05-13       Impact factor: 15.992

10.  Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells.

Authors:  Sunny Das; Brian P Chadwick
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more
  6 in total

1.  FSHD1 and FSHD2 form a disease continuum.

Authors:  Sabrina Sacconi; Audrey Briand-Suleau; Marilyn Gros; Christian Baudoin; Richard J L F Lemmers; Sophie Rondeau; Nadira Lagha; Pilvi Nigumann; Chiara Cambieri; Angela Puma; Françoise Chapon; Tanya Stojkovic; Christophe Vial; Françoise Bouhour; Michelangelo Cao; Elena Pegoraro; Philippe Petiot; Anthony Behin; Bras Marc; Bruno Eymard; Andoni Echaniz-Laguna; Pascal Laforet; Leonardo Salviati; Marc Jeanpierre; Gaël Cristofari; Silvère M van der Maarel
Journal:  Neurology       Date:  2019-04-12       Impact factor: 9.910

Review 2.  Does DNA Methylation Matter in FSHD?

Authors:  Valentina Salsi; Frédérique Magdinier; Rossella Tupler
Journal:  Genes (Basel)       Date:  2020-02-28       Impact factor: 4.096

Review 3.  A scoping review and proposed workflow for multi-omic rare disease research.

Authors:  Katie Kerr; Helen McAneney; Laura J Smyth; Caitlin Bailie; Shane McKee; Amy Jayne McKnight
Journal:  Orphanet J Rare Dis       Date:  2020-04-28       Impact factor: 4.123

4.  A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression.

Authors:  Remko Goossens; Mara S Tihaya; Anita van den Heuvel; Klorane Tabot-Ndip; Iris M Willemsen; Stephen J Tapscott; Román González-Prieto; Jer-Gung Chang; Alfred C O Vertegaal; Judit Balog; Silvère M van der Maarel
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.996

Review 5.  Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.

Authors:  Anna Greco; Remko Goossens; Baziel van Engelen; Silvère M van der Maarel
Journal:  Clin Genet       Date:  2020-03-04       Impact factor: 4.438

Review 6.  DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation.

Authors:  Eva Sidlauskaite; Laura Le Gall; Virginie Mariot; Julie Dumonceaux
Journal:  J Pers Med       Date:  2020-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.